Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis

Emese Balogh, Anita Pusztai, Attila Hamar, Edit Végh, Szilvia Szamosi, György Kerekes, Jennifer McCormick, Monika Biniecka, Sándor Szántó, Gabriella Szűcs, Zoltán Nagy, Ursula Fearon, Douglas J. Veale, Zoltán Szekanecz

Research output: Contribution to journalArticle


Several inflammatory, proteolytic, angiogenic and bone-associated factors play a role in the development of autoimmune, accelerated atherosclerosis in rheumatic diseases. Some of these may serve as biomarkers of vascular pathology and may be useful in the follow-up of vascular damage and outcome. Multi-biomarker profiles rather than a single markers would likely be optimal in this respect.

Original languageEnglish
Pages (from-to)47-51
Number of pages5
JournalClinical Immunology
Publication statusPublished - Feb 2019



  • Angiogenesis
  • Autoimmune atherosclerosis
  • Autoimmunity
  • Biomarkers
  • Cardiovascular disease

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Balogh, E., Pusztai, A., Hamar, A., Végh, E., Szamosi, S., Kerekes, G., McCormick, J., Biniecka, M., Szántó, S., Szűcs, G., Nagy, Z., Fearon, U., Veale, D. J., & Szekanecz, Z. (2019). Autoimmune and angiogenic biomarkers in autoimmune atherosclerosis. Clinical Immunology, 199, 47-51.